Hyperinsulinemia predicts low tissue plasminogen activator activity in a healthy population: The Northern Sweden MONICA study
- 1 December 1994
- journal article
- Published by Elsevier in Metabolism
- Vol. 43 (12) , 1579-1586
- https://doi.org/10.1016/0026-0495(94)90020-5
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Insulin treatment improves microalbuminuria and other cardiovascular risk factors in patients with type 2 diabetes mellitusJournal of Internal Medicine, 1994
- Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart StudyThe Lancet, 1993
- Endogenous tissue-type plasminogen activator and risk of myocardial infarctionThe Lancet, 1993
- Haemostatic factors in coronary heart diseaseJournal of Internal Medicine, 1993
- Effects of Metformin on Insulin Resistance, Risk Factors for Cardiovascular Disease, and Plasminogen Activator Inhibitor in NIDDM Subjects: A study of two ethnic groupsDiabetes Care, 1993
- Insulin Therapy in Type 2 Diabetic Subjects Suppresses Plasminogen Activator Inhibitor (PAI‐1) Activity and Proinsulin‐like Molecules Independently of Glycaemic ControlDiabetic Medicine, 1993
- Is Insulin Atherogenic?Diabetic Medicine, 1992
- Measurement of Insulin Secretion in Type 2 Diabetes: Problems and PitfallsDiabetic Medicine, 1992
- Diabetes, fibrinogen, and risk of cardiovascular disease: The Framingham experienceAmerican Heart Journal, 1990
- Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial InfarctionNew England Journal of Medicine, 1980